Dendritic cell subtypes work in concert to activate each other and trigger different immunological responses 1. “The end goal of immunotherapy is to activate antitumor T cells and we are ...

As dendritic cells increasingly become the adjuvant of choice in new approaches to cancer immunotherapy, a degree of protocol standardization is required to aid future large-scale clinical trials.

Dendritic cells (DCs ... By contrast, foreign antigens result in DC maturation and DC-induced T-cell activation. Inappropriate maturation of DCs due to infections or tissue injury may cause ...

Dendritic cells are poised to revolutionize oncology. This type of immune therapy shows effectiveness even in late-stage ...

Recent advances in immunotherapy research have revealed crucial roles for new immune cells in combating cancer, leading to ...

Various cell types contribute to dysregulation of immune responses in MDS. Dendritic cells (DCs) are important regulators of immunity. However, the role of DCs in MDS has yet to be elucidated.

In recent decades, immunotherapy has transformed cancer treatment, offering effective options for diseases once considered ...

Entinostat yielded increases in dendritic cell activation and maturation. In a small subset of PDA patients, entinostat and ...